nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadobenate Dimeglumine—Face oedema—Doxorubicin—bone cancer	0.00162	0.00162	CcSEcCtD
Gadobenate Dimeglumine—Abdominal discomfort—Methotrexate—bone cancer	0.00161	0.00161	CcSEcCtD
Gadobenate Dimeglumine—Alanine aminotransferase increased—Epirubicin—bone cancer	0.0016	0.0016	CcSEcCtD
Gadobenate Dimeglumine—Cardiac arrest—Doxorubicin—bone cancer	0.0016	0.0016	CcSEcCtD
Gadobenate Dimeglumine—Musculoskeletal discomfort—Cisplatin—bone cancer	0.00158	0.00158	CcSEcCtD
Gadobenate Dimeglumine—Blood creatinine increased—Doxorubicin—bone cancer	0.00158	0.00158	CcSEcCtD
Gadobenate Dimeglumine—Asthma—Epirubicin—bone cancer	0.00157	0.00157	CcSEcCtD
Gadobenate Dimeglumine—Paraesthesia—Cisplatin—bone cancer	0.00156	0.00156	CcSEcCtD
Gadobenate Dimeglumine—Liver function test abnormal—Doxorubicin—bone cancer	0.00155	0.00155	CcSEcCtD
Gadobenate Dimeglumine—Dyspnoea—Cisplatin—bone cancer	0.00155	0.00155	CcSEcCtD
Gadobenate Dimeglumine—Aspartate aminotransferase increased—Doxorubicin—bone cancer	0.00151	0.00151	CcSEcCtD
Gadobenate Dimeglumine—Bronchitis—Epirubicin—bone cancer	0.00151	0.00151	CcSEcCtD
Gadobenate Dimeglumine—Nasopharyngitis—Doxorubicin—bone cancer	0.0015	0.0015	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal disorder—Cisplatin—bone cancer	0.0015	0.0015	CcSEcCtD
Gadobenate Dimeglumine—Infestation NOS—Methotrexate—bone cancer	0.0015	0.0015	CcSEcCtD
Gadobenate Dimeglumine—Infestation—Methotrexate—bone cancer	0.0015	0.0015	CcSEcCtD
Gadobenate Dimeglumine—Pain—Cisplatin—bone cancer	0.00149	0.00149	CcSEcCtD
Gadobenate Dimeglumine—Alanine aminotransferase increased—Doxorubicin—bone cancer	0.00148	0.00148	CcSEcCtD
Gadobenate Dimeglumine—Renal failure—Methotrexate—bone cancer	0.00147	0.00147	CcSEcCtD
Gadobenate Dimeglumine—Conjunctivitis—Methotrexate—bone cancer	0.00145	0.00145	CcSEcCtD
Gadobenate Dimeglumine—Asthma—Doxorubicin—bone cancer	0.00145	0.00145	CcSEcCtD
Gadobenate Dimeglumine—Pollakiuria—Epirubicin—bone cancer	0.00145	0.00145	CcSEcCtD
Gadobenate Dimeglumine—Sweating—Methotrexate—bone cancer	0.00143	0.00143	CcSEcCtD
Gadobenate Dimeglumine—Feeling abnormal—Cisplatin—bone cancer	0.00143	0.00143	CcSEcCtD
Gadobenate Dimeglumine—Haematuria—Methotrexate—bone cancer	0.00143	0.00143	CcSEcCtD
Gadobenate Dimeglumine—Hyperglycaemia—Epirubicin—bone cancer	0.00142	0.00142	CcSEcCtD
Gadobenate Dimeglumine—Infestation NOS—Epirubicin—bone cancer	0.0014	0.0014	CcSEcCtD
Gadobenate Dimeglumine—Infestation—Epirubicin—bone cancer	0.0014	0.0014	CcSEcCtD
Gadobenate Dimeglumine—Bronchitis—Doxorubicin—bone cancer	0.0014	0.0014	CcSEcCtD
Gadobenate Dimeglumine—Renal failure—Epirubicin—bone cancer	0.00138	0.00138	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Cisplatin—bone cancer	0.00138	0.00138	CcSEcCtD
Gadobenate Dimeglumine—Conjunctivitis—Epirubicin—bone cancer	0.00136	0.00136	CcSEcCtD
Gadobenate Dimeglumine—Urinary tract infection—Epirubicin—bone cancer	0.00136	0.00136	CcSEcCtD
Gadobenate Dimeglumine—Sweating—Epirubicin—bone cancer	0.00134	0.00134	CcSEcCtD
Gadobenate Dimeglumine—Pollakiuria—Doxorubicin—bone cancer	0.00134	0.00134	CcSEcCtD
Gadobenate Dimeglumine—Haematuria—Epirubicin—bone cancer	0.00134	0.00134	CcSEcCtD
Gadobenate Dimeglumine—Urinary tract disorder—Methotrexate—bone cancer	0.00133	0.00133	CcSEcCtD
Gadobenate Dimeglumine—Urethral disorder—Methotrexate—bone cancer	0.00132	0.00132	CcSEcCtD
Gadobenate Dimeglumine—Hyperglycaemia—Doxorubicin—bone cancer	0.00131	0.00131	CcSEcCtD
Gadobenate Dimeglumine—Infestation NOS—Doxorubicin—bone cancer	0.0013	0.0013	CcSEcCtD
Gadobenate Dimeglumine—Infestation—Doxorubicin—bone cancer	0.0013	0.0013	CcSEcCtD
Gadobenate Dimeglumine—Visual impairment—Methotrexate—bone cancer	0.00129	0.00129	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Cisplatin—bone cancer	0.00128	0.00128	CcSEcCtD
Gadobenate Dimeglumine—Bradycardia—Epirubicin—bone cancer	0.00128	0.00128	CcSEcCtD
Gadobenate Dimeglumine—Renal failure—Doxorubicin—bone cancer	0.00127	0.00127	CcSEcCtD
Gadobenate Dimeglumine—Rhinitis—Epirubicin—bone cancer	0.00126	0.00126	CcSEcCtD
Gadobenate Dimeglumine—Conjunctivitis—Doxorubicin—bone cancer	0.00126	0.00126	CcSEcCtD
Gadobenate Dimeglumine—Urinary tract infection—Doxorubicin—bone cancer	0.00126	0.00126	CcSEcCtD
Gadobenate Dimeglumine—Eye disorder—Methotrexate—bone cancer	0.00126	0.00126	CcSEcCtD
Gadobenate Dimeglumine—Tinnitus—Methotrexate—bone cancer	0.00125	0.00125	CcSEcCtD
Gadobenate Dimeglumine—Hypoaesthesia—Epirubicin—bone cancer	0.00125	0.00125	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Cisplatin—bone cancer	0.00125	0.00125	CcSEcCtD
Gadobenate Dimeglumine—Cardiac disorder—Methotrexate—bone cancer	0.00125	0.00125	CcSEcCtD
Gadobenate Dimeglumine—Sweating—Doxorubicin—bone cancer	0.00124	0.00124	CcSEcCtD
Gadobenate Dimeglumine—Urinary tract disorder—Epirubicin—bone cancer	0.00124	0.00124	CcSEcCtD
Gadobenate Dimeglumine—Oedema peripheral—Epirubicin—bone cancer	0.00124	0.00124	CcSEcCtD
Gadobenate Dimeglumine—Haematuria—Doxorubicin—bone cancer	0.00124	0.00124	CcSEcCtD
Gadobenate Dimeglumine—Connective tissue disorder—Epirubicin—bone cancer	0.00124	0.00124	CcSEcCtD
Gadobenate Dimeglumine—Urethral disorder—Epirubicin—bone cancer	0.00123	0.00123	CcSEcCtD
Gadobenate Dimeglumine—Angiopathy—Methotrexate—bone cancer	0.00122	0.00122	CcSEcCtD
Gadobenate Dimeglumine—Immune system disorder—Methotrexate—bone cancer	0.00121	0.00121	CcSEcCtD
Gadobenate Dimeglumine—Visual impairment—Epirubicin—bone cancer	0.00121	0.00121	CcSEcCtD
Gadobenate Dimeglumine—Mediastinal disorder—Methotrexate—bone cancer	0.00121	0.00121	CcSEcCtD
Gadobenate Dimeglumine—Chills—Methotrexate—bone cancer	0.00121	0.00121	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Cisplatin—bone cancer	0.00119	0.00119	CcSEcCtD
Gadobenate Dimeglumine—Bradycardia—Doxorubicin—bone cancer	0.00118	0.00118	CcSEcCtD
Gadobenate Dimeglumine—Mental disorder—Methotrexate—bone cancer	0.00118	0.00118	CcSEcCtD
Gadobenate Dimeglumine—Eye disorder—Epirubicin—bone cancer	0.00118	0.00118	CcSEcCtD
Gadobenate Dimeglumine—Tinnitus—Epirubicin—bone cancer	0.00117	0.00117	CcSEcCtD
Gadobenate Dimeglumine—Erythema—Methotrexate—bone cancer	0.00117	0.00117	CcSEcCtD
Gadobenate Dimeglumine—Malnutrition—Methotrexate—bone cancer	0.00117	0.00117	CcSEcCtD
Gadobenate Dimeglumine—Cardiac disorder—Epirubicin—bone cancer	0.00117	0.00117	CcSEcCtD
Gadobenate Dimeglumine—Flushing—Epirubicin—bone cancer	0.00117	0.00117	CcSEcCtD
Gadobenate Dimeglumine—Rhinitis—Doxorubicin—bone cancer	0.00117	0.00117	CcSEcCtD
Gadobenate Dimeglumine—Hypoaesthesia—Doxorubicin—bone cancer	0.00116	0.00116	CcSEcCtD
Gadobenate Dimeglumine—Urinary tract disorder—Doxorubicin—bone cancer	0.00115	0.00115	CcSEcCtD
Gadobenate Dimeglumine—Oedema peripheral—Doxorubicin—bone cancer	0.00115	0.00115	CcSEcCtD
Gadobenate Dimeglumine—Dysgeusia—Methotrexate—bone cancer	0.00115	0.00115	CcSEcCtD
Gadobenate Dimeglumine—Connective tissue disorder—Doxorubicin—bone cancer	0.00114	0.00114	CcSEcCtD
Gadobenate Dimeglumine—Angiopathy—Epirubicin—bone cancer	0.00114	0.00114	CcSEcCtD
Gadobenate Dimeglumine—Urethral disorder—Doxorubicin—bone cancer	0.00114	0.00114	CcSEcCtD
Gadobenate Dimeglumine—Immune system disorder—Epirubicin—bone cancer	0.00114	0.00114	CcSEcCtD
Gadobenate Dimeglumine—Mediastinal disorder—Epirubicin—bone cancer	0.00113	0.00113	CcSEcCtD
Gadobenate Dimeglumine—Back pain—Methotrexate—bone cancer	0.00113	0.00113	CcSEcCtD
Gadobenate Dimeglumine—Chills—Epirubicin—bone cancer	0.00113	0.00113	CcSEcCtD
Gadobenate Dimeglumine—Arrhythmia—Epirubicin—bone cancer	0.00112	0.00112	CcSEcCtD
Gadobenate Dimeglumine—Visual impairment—Doxorubicin—bone cancer	0.00112	0.00112	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Cisplatin—bone cancer	0.00111	0.00111	CcSEcCtD
Gadobenate Dimeglumine—Mental disorder—Epirubicin—bone cancer	0.0011	0.0011	CcSEcCtD
Gadobenate Dimeglumine—Rash—Cisplatin—bone cancer	0.0011	0.0011	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Cisplatin—bone cancer	0.0011	0.0011	CcSEcCtD
Gadobenate Dimeglumine—Malnutrition—Epirubicin—bone cancer	0.00109	0.00109	CcSEcCtD
Gadobenate Dimeglumine—Erythema—Epirubicin—bone cancer	0.00109	0.00109	CcSEcCtD
Gadobenate Dimeglumine—Eye disorder—Doxorubicin—bone cancer	0.00109	0.00109	CcSEcCtD
Gadobenate Dimeglumine—Ill-defined disorder—Methotrexate—bone cancer	0.00109	0.00109	CcSEcCtD
Gadobenate Dimeglumine—Tinnitus—Doxorubicin—bone cancer	0.00108	0.00108	CcSEcCtD
Gadobenate Dimeglumine—Anaemia—Methotrexate—bone cancer	0.00108	0.00108	CcSEcCtD
Gadobenate Dimeglumine—Cardiac disorder—Doxorubicin—bone cancer	0.00108	0.00108	CcSEcCtD
Gadobenate Dimeglumine—Flushing—Doxorubicin—bone cancer	0.00108	0.00108	CcSEcCtD
Gadobenate Dimeglumine—Dysgeusia—Epirubicin—bone cancer	0.00107	0.00107	CcSEcCtD
Gadobenate Dimeglumine—Back pain—Epirubicin—bone cancer	0.00106	0.00106	CcSEcCtD
Gadobenate Dimeglumine—Angiopathy—Doxorubicin—bone cancer	0.00106	0.00106	CcSEcCtD
Gadobenate Dimeglumine—Malaise—Methotrexate—bone cancer	0.00105	0.00105	CcSEcCtD
Gadobenate Dimeglumine—Muscle spasms—Epirubicin—bone cancer	0.00105	0.00105	CcSEcCtD
Gadobenate Dimeglumine—Immune system disorder—Doxorubicin—bone cancer	0.00105	0.00105	CcSEcCtD
Gadobenate Dimeglumine—Mediastinal disorder—Doxorubicin—bone cancer	0.00105	0.00105	CcSEcCtD
Gadobenate Dimeglumine—Leukopenia—Methotrexate—bone cancer	0.00105	0.00105	CcSEcCtD
Gadobenate Dimeglumine—Chills—Doxorubicin—bone cancer	0.00104	0.00104	CcSEcCtD
Gadobenate Dimeglumine—Arrhythmia—Doxorubicin—bone cancer	0.00104	0.00104	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Cisplatin—bone cancer	0.00103	0.00103	CcSEcCtD
Gadobenate Dimeglumine—Cough—Methotrexate—bone cancer	0.00102	0.00102	CcSEcCtD
Gadobenate Dimeglumine—Mental disorder—Doxorubicin—bone cancer	0.00102	0.00102	CcSEcCtD
Gadobenate Dimeglumine—Ill-defined disorder—Epirubicin—bone cancer	0.00102	0.00102	CcSEcCtD
Gadobenate Dimeglumine—Erythema—Doxorubicin—bone cancer	0.00101	0.00101	CcSEcCtD
Gadobenate Dimeglumine—Malnutrition—Doxorubicin—bone cancer	0.00101	0.00101	CcSEcCtD
Gadobenate Dimeglumine—Anaemia—Epirubicin—bone cancer	0.00101	0.00101	CcSEcCtD
Gadobenate Dimeglumine—Arthralgia—Methotrexate—bone cancer	0.000996	0.000996	CcSEcCtD
Gadobenate Dimeglumine—Myalgia—Methotrexate—bone cancer	0.000996	0.000996	CcSEcCtD
Gadobenate Dimeglumine—Chest pain—Methotrexate—bone cancer	0.000996	0.000996	CcSEcCtD
Gadobenate Dimeglumine—Dysgeusia—Doxorubicin—bone cancer	0.000992	0.000992	CcSEcCtD
Gadobenate Dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	0.000989	0.000989	CcSEcCtD
Gadobenate Dimeglumine—Malaise—Epirubicin—bone cancer	0.000987	0.000987	CcSEcCtD
Gadobenate Dimeglumine—Discomfort—Methotrexate—bone cancer	0.000984	0.000984	CcSEcCtD
Gadobenate Dimeglumine—Syncope—Epirubicin—bone cancer	0.000982	0.000982	CcSEcCtD
Gadobenate Dimeglumine—Leukopenia—Epirubicin—bone cancer	0.00098	0.00098	CcSEcCtD
Gadobenate Dimeglumine—Back pain—Doxorubicin—bone cancer	0.00098	0.00098	CcSEcCtD
Gadobenate Dimeglumine—Muscle spasms—Doxorubicin—bone cancer	0.000974	0.000974	CcSEcCtD
Gadobenate Dimeglumine—Palpitations—Epirubicin—bone cancer	0.000967	0.000967	CcSEcCtD
Gadobenate Dimeglumine—Confusional state—Methotrexate—bone cancer	0.000963	0.000963	CcSEcCtD
Gadobenate Dimeglumine—Loss of consciousness—Epirubicin—bone cancer	0.000962	0.000962	CcSEcCtD
Gadobenate Dimeglumine—Cough—Epirubicin—bone cancer	0.000955	0.000955	CcSEcCtD
Gadobenate Dimeglumine—Anaphylactic shock—Methotrexate—bone cancer	0.000955	0.000955	CcSEcCtD
Gadobenate Dimeglumine—Infection—Methotrexate—bone cancer	0.000948	0.000948	CcSEcCtD
Gadobenate Dimeglumine—Hypertension—Epirubicin—bone cancer	0.000945	0.000945	CcSEcCtD
Gadobenate Dimeglumine—Ill-defined disorder—Doxorubicin—bone cancer	0.00094	0.00094	CcSEcCtD
Gadobenate Dimeglumine—Nervous system disorder—Methotrexate—bone cancer	0.000936	0.000936	CcSEcCtD
Gadobenate Dimeglumine—Anaemia—Doxorubicin—bone cancer	0.000936	0.000936	CcSEcCtD
Gadobenate Dimeglumine—Chest pain—Epirubicin—bone cancer	0.000932	0.000932	CcSEcCtD
Gadobenate Dimeglumine—Arthralgia—Epirubicin—bone cancer	0.000932	0.000932	CcSEcCtD
Gadobenate Dimeglumine—Myalgia—Epirubicin—bone cancer	0.000932	0.000932	CcSEcCtD
Gadobenate Dimeglumine—Anxiety—Epirubicin—bone cancer	0.000929	0.000929	CcSEcCtD
Gadobenate Dimeglumine—Skin disorder—Methotrexate—bone cancer	0.000927	0.000927	CcSEcCtD
Gadobenate Dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	0.000926	0.000926	CcSEcCtD
Gadobenate Dimeglumine—Hyperhidrosis—Methotrexate—bone cancer	0.000923	0.000923	CcSEcCtD
Gadobenate Dimeglumine—Discomfort—Epirubicin—bone cancer	0.000921	0.000921	CcSEcCtD
Gadobenate Dimeglumine—Malaise—Doxorubicin—bone cancer	0.000913	0.000913	CcSEcCtD
Gadobenate Dimeglumine—Dry mouth—Epirubicin—bone cancer	0.000911	0.000911	CcSEcCtD
Gadobenate Dimeglumine—Syncope—Doxorubicin—bone cancer	0.000908	0.000908	CcSEcCtD
Gadobenate Dimeglumine—Leukopenia—Doxorubicin—bone cancer	0.000907	0.000907	CcSEcCtD
Gadobenate Dimeglumine—Confusional state—Epirubicin—bone cancer	0.000901	0.000901	CcSEcCtD
Gadobenate Dimeglumine—Palpitations—Doxorubicin—bone cancer	0.000895	0.000895	CcSEcCtD
Gadobenate Dimeglumine—Anaphylactic shock—Epirubicin—bone cancer	0.000893	0.000893	CcSEcCtD
Gadobenate Dimeglumine—Hypotension—Methotrexate—bone cancer	0.000892	0.000892	CcSEcCtD
Gadobenate Dimeglumine—Loss of consciousness—Doxorubicin—bone cancer	0.00089	0.00089	CcSEcCtD
Gadobenate Dimeglumine—Infection—Epirubicin—bone cancer	0.000888	0.000888	CcSEcCtD
Gadobenate Dimeglumine—Cough—Doxorubicin—bone cancer	0.000884	0.000884	CcSEcCtD
Gadobenate Dimeglumine—Shock—Epirubicin—bone cancer	0.000879	0.000879	CcSEcCtD
Gadobenate Dimeglumine—Nervous system disorder—Epirubicin—bone cancer	0.000876	0.000876	CcSEcCtD
Gadobenate Dimeglumine—Hypertension—Doxorubicin—bone cancer	0.000874	0.000874	CcSEcCtD
Gadobenate Dimeglumine—Tachycardia—Epirubicin—bone cancer	0.000872	0.000872	CcSEcCtD
Gadobenate Dimeglumine—Musculoskeletal discomfort—Methotrexate—bone cancer	0.00087	0.00087	CcSEcCtD
Gadobenate Dimeglumine—Skin disorder—Epirubicin—bone cancer	0.000868	0.000868	CcSEcCtD
Gadobenate Dimeglumine—Hyperhidrosis—Epirubicin—bone cancer	0.000864	0.000864	CcSEcCtD
Gadobenate Dimeglumine—Myalgia—Doxorubicin—bone cancer	0.000862	0.000862	CcSEcCtD
Gadobenate Dimeglumine—Chest pain—Doxorubicin—bone cancer	0.000862	0.000862	CcSEcCtD
Gadobenate Dimeglumine—Arthralgia—Doxorubicin—bone cancer	0.000862	0.000862	CcSEcCtD
Gadobenate Dimeglumine—Anxiety—Doxorubicin—bone cancer	0.000859	0.000859	CcSEcCtD
Gadobenate Dimeglumine—Paraesthesia—Methotrexate—bone cancer	0.000857	0.000857	CcSEcCtD
Gadobenate Dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	0.000856	0.000856	CcSEcCtD
Gadobenate Dimeglumine—Discomfort—Doxorubicin—bone cancer	0.000852	0.000852	CcSEcCtD
Gadobenate Dimeglumine—Dyspnoea—Methotrexate—bone cancer	0.000851	0.000851	CcSEcCtD
Gadobenate Dimeglumine—Somnolence—Methotrexate—bone cancer	0.000849	0.000849	CcSEcCtD
Gadobenate Dimeglumine—Dry mouth—Doxorubicin—bone cancer	0.000843	0.000843	CcSEcCtD
Gadobenate Dimeglumine—Dyspepsia—Methotrexate—bone cancer	0.00084	0.00084	CcSEcCtD
Gadobenate Dimeglumine—Hypotension—Epirubicin—bone cancer	0.000835	0.000835	CcSEcCtD
Gadobenate Dimeglumine—Confusional state—Doxorubicin—bone cancer	0.000833	0.000833	CcSEcCtD
Gadobenate Dimeglumine—Anaphylactic shock—Doxorubicin—bone cancer	0.000827	0.000827	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal disorder—Methotrexate—bone cancer	0.000824	0.000824	CcSEcCtD
Gadobenate Dimeglumine—Fatigue—Methotrexate—bone cancer	0.000823	0.000823	CcSEcCtD
Gadobenate Dimeglumine—Infection—Doxorubicin—bone cancer	0.000821	0.000821	CcSEcCtD
Gadobenate Dimeglumine—Pain—Methotrexate—bone cancer	0.000816	0.000816	CcSEcCtD
Gadobenate Dimeglumine—Musculoskeletal discomfort—Epirubicin—bone cancer	0.000814	0.000814	CcSEcCtD
Gadobenate Dimeglumine—Shock—Doxorubicin—bone cancer	0.000813	0.000813	CcSEcCtD
Gadobenate Dimeglumine—Nervous system disorder—Doxorubicin—bone cancer	0.000811	0.000811	CcSEcCtD
Gadobenate Dimeglumine—Tachycardia—Doxorubicin—bone cancer	0.000807	0.000807	CcSEcCtD
Gadobenate Dimeglumine—Skin disorder—Doxorubicin—bone cancer	0.000803	0.000803	CcSEcCtD
Gadobenate Dimeglumine—Paraesthesia—Epirubicin—bone cancer	0.000802	0.000802	CcSEcCtD
Gadobenate Dimeglumine—Hyperhidrosis—Doxorubicin—bone cancer	0.000799	0.000799	CcSEcCtD
Gadobenate Dimeglumine—Dyspnoea—Epirubicin—bone cancer	0.000796	0.000796	CcSEcCtD
Gadobenate Dimeglumine—Somnolence—Epirubicin—bone cancer	0.000794	0.000794	CcSEcCtD
Gadobenate Dimeglumine—Feeling abnormal—Methotrexate—bone cancer	0.000787	0.000787	CcSEcCtD
Gadobenate Dimeglumine—Dyspepsia—Epirubicin—bone cancer	0.000786	0.000786	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal pain—Methotrexate—bone cancer	0.000781	0.000781	CcSEcCtD
Gadobenate Dimeglumine—Hypotension—Doxorubicin—bone cancer	0.000772	0.000772	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal disorder—Epirubicin—bone cancer	0.000771	0.000771	CcSEcCtD
Gadobenate Dimeglumine—Fatigue—Epirubicin—bone cancer	0.00077	0.00077	CcSEcCtD
Gadobenate Dimeglumine—Pain—Epirubicin—bone cancer	0.000764	0.000764	CcSEcCtD
Gadobenate Dimeglumine—Constipation—Epirubicin—bone cancer	0.000764	0.000764	CcSEcCtD
Gadobenate Dimeglumine—Urticaria—Methotrexate—bone cancer	0.000758	0.000758	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Methotrexate—bone cancer	0.000755	0.000755	CcSEcCtD
Gadobenate Dimeglumine—Abdominal pain—Methotrexate—bone cancer	0.000755	0.000755	CcSEcCtD
Gadobenate Dimeglumine—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.000753	0.000753	CcSEcCtD
Gadobenate Dimeglumine—Paraesthesia—Doxorubicin—bone cancer	0.000742	0.000742	CcSEcCtD
Gadobenate Dimeglumine—Dyspnoea—Doxorubicin—bone cancer	0.000737	0.000737	CcSEcCtD
Gadobenate Dimeglumine—Feeling abnormal—Epirubicin—bone cancer	0.000736	0.000736	CcSEcCtD
Gadobenate Dimeglumine—Somnolence—Doxorubicin—bone cancer	0.000735	0.000735	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal pain—Epirubicin—bone cancer	0.000731	0.000731	CcSEcCtD
Gadobenate Dimeglumine—Dyspepsia—Doxorubicin—bone cancer	0.000728	0.000728	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal disorder—Doxorubicin—bone cancer	0.000714	0.000714	CcSEcCtD
Gadobenate Dimeglumine—Fatigue—Doxorubicin—bone cancer	0.000713	0.000713	CcSEcCtD
Gadobenate Dimeglumine—Urticaria—Epirubicin—bone cancer	0.00071	0.00071	CcSEcCtD
Gadobenate Dimeglumine—Pain—Doxorubicin—bone cancer	0.000707	0.000707	CcSEcCtD
Gadobenate Dimeglumine—Constipation—Doxorubicin—bone cancer	0.000707	0.000707	CcSEcCtD
Gadobenate Dimeglumine—Abdominal pain—Epirubicin—bone cancer	0.000706	0.000706	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Epirubicin—bone cancer	0.000706	0.000706	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Methotrexate—bone cancer	0.000703	0.000703	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Methotrexate—bone cancer	0.000685	0.000685	CcSEcCtD
Gadobenate Dimeglumine—Feeling abnormal—Doxorubicin—bone cancer	0.000681	0.000681	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal pain—Doxorubicin—bone cancer	0.000676	0.000676	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Methotrexate—bone cancer	0.000675	0.000675	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Epirubicin—bone cancer	0.000658	0.000658	CcSEcCtD
Gadobenate Dimeglumine—Urticaria—Doxorubicin—bone cancer	0.000657	0.000657	CcSEcCtD
Gadobenate Dimeglumine—Abdominal pain—Doxorubicin—bone cancer	0.000653	0.000653	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Doxorubicin—bone cancer	0.000653	0.000653	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Methotrexate—bone cancer	0.000653	0.000653	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Epirubicin—bone cancer	0.000641	0.000641	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Epirubicin—bone cancer	0.000632	0.000632	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Methotrexate—bone cancer	0.000631	0.000631	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Epirubicin—bone cancer	0.000611	0.000611	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Doxorubicin—bone cancer	0.000609	0.000609	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Methotrexate—bone cancer	0.000607	0.000607	CcSEcCtD
Gadobenate Dimeglumine—Rash—Methotrexate—bone cancer	0.000602	0.000602	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Methotrexate—bone cancer	0.000601	0.000601	CcSEcCtD
Gadobenate Dimeglumine—Headache—Methotrexate—bone cancer	0.000598	0.000598	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Doxorubicin—bone cancer	0.000593	0.000593	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Epirubicin—bone cancer	0.000591	0.000591	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Doxorubicin—bone cancer	0.000585	0.000585	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Epirubicin—bone cancer	0.000568	0.000568	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Methotrexate—bone cancer	0.000567	0.000567	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Doxorubicin—bone cancer	0.000566	0.000566	CcSEcCtD
Gadobenate Dimeglumine—Rash—Epirubicin—bone cancer	0.000563	0.000563	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Epirubicin—bone cancer	0.000563	0.000563	CcSEcCtD
Gadobenate Dimeglumine—Headache—Epirubicin—bone cancer	0.00056	0.00056	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Doxorubicin—bone cancer	0.000547	0.000547	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Epirubicin—bone cancer	0.000531	0.000531	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Doxorubicin—bone cancer	0.000526	0.000526	CcSEcCtD
Gadobenate Dimeglumine—Rash—Doxorubicin—bone cancer	0.000521	0.000521	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Doxorubicin—bone cancer	0.000521	0.000521	CcSEcCtD
Gadobenate Dimeglumine—Headache—Doxorubicin—bone cancer	0.000518	0.000518	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Doxorubicin—bone cancer	0.000491	0.000491	CcSEcCtD
